Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$211.99 -1.77 (-0.83%)
As of: Oct 21, 2026 · 11:41 AM EDT

Jazz Pharmaceuticals (JAZZ) Total Non-Current Liabilities (2010 - 2026)

Updated

Jazz Pharmaceuticals' Total Non-Current Liabilities was $6.14 billion in Q2 2026, down 14.1% from $7.14 billion a year earlier and down 14.3% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Jazz Pharmaceuticals came in at $7.22 billion, down 7.9% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of 21.1% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $7.83 billion in FY2024 (+3.7%), $7.55 billion in FY2023 (-1.2%), $7.64 billion in FY2022 (-7.0%) and $8.22 billion in FY2021 (+196.1%).
  • The Q2 2026 figure marks the lowest quarterly Total Non-Current Liabilities since Q1 2021.
  • Compared with a year earlier, Total Non-Current Liabilities has declined for six straight quarters, with an average decline of 3.9% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q3 2021 (growth of 203.1%); the worst was Q2 2026 (a decline of 14.1%).
  • Per Business Quant data, JAZZ's Total Non-Current Liabilities in the three quarters before Q2 2026 was $7.17 billion (Q1 2026), $7.22 billion (Q4 2025) and $7.29 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 105.50 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 106.45 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 33.91 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 35.10 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 97.04 Bn
10 Jazz Pharmaceuticals 13.41 Bn 7.22 Bn 1.09 Bn 6.14 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.14 Bn
Mar 31, 2026 7.17 Bn
Dec 31, 2025 7.22 Bn
Sep 30, 2025 7.29 Bn
Jun 30, 2025 7.14 Bn
Mar 31, 2025 7.27 Bn
Dec 31, 2024 7.83 Bn
Sep 30, 2024 7.97 Bn
Jun 30, 2024 7.50 Bn
Mar 31, 2024 7.53 Bn
Dec 31, 2023 7.55 Bn
Sep 30, 2023 7.59 Bn
Jun 30, 2023 7.61 Bn
Mar 31, 2023 7.60 Bn
Dec 31, 2022 7.64 Bn
Sep 30, 2022 7.52 Bn
Jun 30, 2022 7.87 Bn
Mar 31, 2022 8.04 Bn
Dec 31, 2021 8.22 Bn
Sep 30, 2021 8.40 Bn
API Access

Jazz Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=JAZZ&period=max&api_key=YOUR_API_KEY